M 172
Pill imprint M 172 has been identified as Metolazone 2.5 mg.
Metolazone is used in the treatment of edema; high blood pressure and belongs to the drug class thiazide diuretics. There is no proven risk in humans during pregnancy.
Metolazone 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Metolazone Images
- Imprint:
-
M
172 - Strength:
- 2.5 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
- Drug Class:
- Thiazide diuretics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-6172
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0023 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
Advertisement
More Metolazone resources
- Metolazone (Wolters Kluwer)
- metolazone (Cerner Multum)
- metolazone (Micromedex) - Includes Dosage Information
- Metolazone (AHFS DI)
- Metolazone (FDA)
- Metolazone (Wolters Kluwer)
Search Again
